- cafead   Jul 29, 2024 at 10:52: AM
via
article source
- Pfizer is in the midst of a strategic transition to new sources of revenue.
- It has enough capital to ease that transition by making acquisitions.
- There's a good chance its next acquisitions will be focused on a certain area.
article source